Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,609.50
+11.50 (0.72%)
Sep 18, 2026, 3:30 PM JST
Sumitomo Pharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sumitomo Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,114. The average 1-year stock price forecast is 31.36% higher than the current stock price, while the lowest is ¥1,500 (-6.80%) and the highest is ¥2,700 (+67.75%).
Price Target: ¥2,114 (+31.36%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sumitomo Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ¥2,400 → ¥2,700 | Buy | Maintains | ¥2,400 → ¥2,700 | +67.75% | Sep 14, 2026 |
| Citi | Citi | Sell Maintains ¥1,500 | Sell | Maintains | ¥1,500 | -6.80% | May 26, 2026 |
Financial Forecast
Revenue This Year
563.24B
from 453.29B
Increased by 24.26%
Revenue Next Year
615.09B
from 563.24B
Increased by 9.20%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.